RIGL NASDAQ
Rigel Pharmaceuticals, Inc.
1W: -8.6%
1M: -4.2%
3M: -17.7%
YTD: -30.2%
1Y: +45.1%
3Y: +126.3%
5Y: -21.3%
$29.01
-0.18 (-0.62%)
Weekly Expected Move ±10.6%
$23
$26
$29
$32
$35
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$300M
Revenue
+47.6% YoY
$364M
Net Income
+879.7% YoY
$79M
Free Cash Flow
+124.4% YoY
92.2%
Gross Margin
20.2%
Op. Margin
14.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE184.5%
ROA107.5%
ROIC128.4%
Valuation
P/E1.5
P/B1.3
EV/EBITDA3.3
Leverage
Debt/Equity0.14
Current Ratio2.42
Interest Cov.18.7x
Quality Scores
Piotroski F6/9
Altman Z1.57
Beneish M1.37